3Me6,7MDTIQ

3Me6,7MDTIQ
Clinical data
Other names3-Methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline; 3-MMOTI
ATC code
  • None
Identifiers
  • 7-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H13NO2
Molar mass191.230 g·mol−1
3D model (JSmol)
  • CC1CC2=CC3=C(C=C2CN1)OCO3
  • InChI=1S/C11H13NO2/c1-7-2-8-3-10-11(14-6-13-10)4-9(8)5-12-7/h3-4,7,12H,2,5-6H2,1H3
  • Key:BGKYNZFHWPNVJF-UHFFFAOYSA-N

3Me6,7MDTIQ, also known as 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline, is a drug of the phenethylamine and tetrahydroisoquinoline families related to the psychedelic and entactogen drug 3,4-methylenedioxyamphetamine (MDA).[1] It is a cyclized phenethylamine and is a known active metabolite of MDA in rodents.[1] In contrast to MDA however, 3Me6,7MDTIQ shows different pharmacological effects, for instance producing hypolocomotion instead of hyperlocomotion.[1] The chemical synthesis of 3Me6,7MDTIQ has been described.[1] 3Me6,7MDTIQ was first described in the scientific literature in 1993.[1]

See also

References

  1. 1 2 3 4 5 Nakagawa H, Makino Y, Yoshida Y, Ohta S, Hirobe M (June 1993). "A novel metabolite of 3,4-methylenedioxyamphetamine (MDA): formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline and its pharmacological effect". Biological & Pharmaceutical Bulletin. 16 (6): 579–582. doi:10.1248/bpb.16.579. PMID 8364510.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.